Monocyte-mediated defense against microbial pathogens

Annual Review of Immunology

Volumn 26, Issue , 2008, Pages 421-452

  Serbina, Natalya V ^a   Jia, Ting ^a   Hohl, Tobias M ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemokines; Inflammation; Microbial pathogens; Monocyte differentiation

Indexed keywords

ANTIGEN; ANTIINFECTIVE AGENT; CHEMOKINE RECEPTOR CCR2; CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

CELL DIFFERENTIATION; CELL POPULATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; INFECTION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MONOCYTE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELL DIFFERENTIATION; CHEMOTAXIS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; INFECTION; MONOCYTE CHEMOATTRACTANT PROTEINS; MONOCYTES; RECEPTORS, CCR2;

EID: 42649108339     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.26.021607.090326     Document Type: Review

References (200)

1. van Furth R, Cohn ZA. 1968. The origin and kinetics of mononuclear phagocytes. J Exp. Med. 128:415-35
2. Van Furth R, Diesselhoff-den Dulk MC, Mattie H. 1973. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J. Exp. Med. 138:1314-30
3. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-64
4. Taylor PR, Gordon S. 2003. Monocyte heterogeneity and innate immunity. Immunity 19:2-4
5. Passlick B, Flieger D, Ziegler-Heitbrock HW. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74:2527-34
6. + blood monocytes is expanded in sepsis patients. Blood 82:3170-76
7. high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25:3418-24
8. ++ monocytes are a major source of TNF. J. Immunol. 168:3536-42
9. Weber C, Belge KU, von Hundeishausen P, Draude G, Steppich B, et al. 2000. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67:699-704
10. + monocytes. J. Exp. Med. 197:1701-7
11. + blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23:2053-58
12. Grage-Griebenow E, Flad HD, Ernst M, Bzowska M, Skrzeczynska J, Pryjma J. 2000. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 202:42-50
13. + blood monocytes. Eur. J. Immunol. 31:48-56
14. + peripheral blood monocyte. Leukemia 19:69-76
15. + blood monocytes in patients with active Crohn's disease. Inflamm. Bowel Dis. 13:566-72
16. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82
17. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-73
18. Henderson RB, Hobbs JA, Mathies M, Hogg N. 2003. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood 102:328-35
19. 3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-14
20. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, et al. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-80
21. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, et al. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-17
22. 3CL1-expressing endothelial cells. J. Leukoc. Biol. 80:1156-64
23. Qu C, Edwards EW, Tacke F, Angeli V, Llodra J, et al. 2004. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200:1231-41
24. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62
25. Iwasaki H, Akashi K. 2007. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26:726-40
26. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-97
27. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
28. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, et al. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311:83-87
29. Serbina NV, Pamer EG. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7:311-17
30. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, et al. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117:902-9
31. Tacke F, Randolph GJ. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-18
32. Yrlid U, Jenkins CD, MacPherson GG. 2006. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J. Immunol. 176:4155-62
33. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-18
34. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480-83
35. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-61
36. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, et al. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-73
37. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70
38. Leon B, Lopez-Bravo M, Ardavin C. 2007. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26:519-31
39. Shortman K, Naik SH. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:19-30
40. Wu L, Liu YJ. 2007. Development of dendritic-cell lineages. Immunity 26:741-50
41. Kamath AT, Pooley J, O'Keeffe MA, Vremec D, Zhan Y, et al. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:6762-70
42. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8:578-83
43. del Hoyo GM, Martin P, Vargas HH, Ruiz S, Arias CF, Ardavin C. 2002. Characterization of a common precursor population for dendritic cells. Nature 415:1043-47
44. + DC1 precursors. Blood 101:1453-59
45. + splenic dendritic cells. Blood 103:2668-76
46. Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, et al. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7:663-71
47. Diao J, Winter E, Cantin C, Chen W, Xu L, et al. 2006. In situ replication of immediate dendritic cell (DC) precursors contributes to conventional DC homeostasis in lymphoid tissue. J. Immunol. 176:7196-206
48. + T cells by exogenous cell-associated antigens. Immunity 17:211-20
49. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. 2003. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171:3128-35
50. Holt PG. 2005. Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc. Am. Thorac. Soc. 2:116-20
51. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176:2161-72
52. Landsman L, Varol C, Jung S. 2007. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178:2000-7
53. Kennedy DW, Abkowitz JL. 1997. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986-93
54. Maus UA, Janzen S, Wall G, Srivastava M, Blackwell TS, et al. 2006. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell Mol. Biol. 35:227-35
55. + myeloid progenitors are the main source of Langerhans cells. Blood 107:1383-90
56. + cells differentiate into Langerhans cells. Nat. Immunol. 2:1151-58
57. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
58. Iwasaki A. 2007. Mucosal dendritic cells. Annu. Rev. Immunol. 25:381-418
59. Wassef JS, Keren DF, Mailloux JL. 1989. Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis. Infect. Immun. 57:858-63
60. Jones BD, Ghori N, Falkow S. 1994. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180:15-23
61. Inman LR, Cantey JR. 1983. Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit. J. Clin. Invest. 71:1-8
62. Grutzkau A, Hanski C, Hahn H, Riecken EO. 1990. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31:1011-15
63. Galan JE. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53-86
64. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-8
65. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, et al. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-67
66. Rescigno M, Rotta G, Valzasina B, Ricciardi-Castagnoli P. 2001. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 204:572-81
67. Chieppa M, Rescigno M, Huang AY, Germain RN. 2006. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203:2841-52
68. Macpherson AJ, Uhr T. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662-65
69. + lamina propria cells. Nat. Immunol. 7:868-74
70. Niess JH, Brand S, Gu X, Landsman L, Jung S, et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-58
71. Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, et al. 2000. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164:3368-76
72. Lucas AD, Chadwick N, Warren BF, Jewell DP, Gordon S, et al. 2001. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am. J. Pathol. 158:855-66
73. Brand S, Sakaguchi T, Gu X, Colgan SP, Reinecker HC. 2002. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122:166-77
74. + cells during oral Salmonella infection. J. Immunol. 175:3287-98
75. Rydstrom A, Wick MJ. 2007. Monocyte recruitment, activation, and function in the gut-associated lymphoid tissue during oral Salmonella infection. J. Immunol. 178:5789-801
76. Murray EGD, Webb RA, Swann MBR. 1926. A disease of rabbits characterized by a large mononuclear monocytosis, caused by a hitherto undescribed bacillus Bacterium monocytogenes. J. Pathol. Bacteriol. 29:407-39
77. Pamer EG. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4:812-23
78. North RJ. 1970. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J. Exp. Med. 132:521-34
79. Fleming TJ, O'hUigin C, Malek TR. 1993. Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins. J. Immunol. 150:5379-90
80. Conlan JW, North RJ. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259-68
81. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. 1994. Administration of antigranulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152:1836-46
82. Rogers HW, Unanue ER. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090-96
83. Rosen H, Gordon S, North RJ. 1989. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells. J. Exp. Med. 170:27-37
84. Berche P. 1995. Bacteremia is required for invasion of the murine central nervous system by Listeria monocytogenes. Microb. Pathog. 18:323-36
85. Marco AJ, Prats N, Ramos JA, Briones V, Blanco M, et al. 1992. A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. J. Comp. Pathol. 107:1-9
86. Drevets DA. 1999. Dissemination of Listeria monocytogenes by infected phagocytes. Infect. Immun. 67:3512-17
87. high monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J. Immunol. 172:4418-24
88. Join-Lambert OF, Ezine S, Le Monnier A, Jaubert F, Okabe M, et al. 2005. Listeria monocytogenes-infected bone marrow myeloid cells promote bacterial invasion of the central nervous system. Cell. Microbiol. 7:167-80
89. Drevets DA, Jelinek TA, Freitag NE. 2001. Listeria monocytogenes-infected phagocytes can initiate central nervous system infection in mice. Infect. Immun. 69:1344-50
90. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820-32
91. Amer AO, Swanson MS. 2002. A phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5:56-61
92. Dinauer MC, Deck MB, Unanue ER. 1997. Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J. Immunol. 158:5581-83
93. 55-/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7:419-32
94. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150:888-95
95. Edelson BT, Unanue ER. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-75
96. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, et al. 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 169:3863-68
97. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, et al. 2007. Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26:215-26
98. Kurihara T, Warr G, Loy J, Bravo R. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757-62
99. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22:93-104
100. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200:527-33
101. Serbina NV, Kuziel W, Flavell R, Akira S, Rollins B, Pamer EG. 2003. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19:891-901
102. Engel D, Dobrindt U, Tittel A, Peters P, Maurer J, et al. 2006. Tumor necrosis factor α- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect. Immun. 74:6100-7
103. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129
104. Scanga CA, Bafica A, Feng CG, Cheever AW, Hieny S, Sher A. 2004. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect. Immun. 72:2400-4
105. Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114:1790-99
106. dim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium tuberculosis. J. Immunol. 172:7647-53
107. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD. 2001. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98:7958-63
108. Peters W, Dupuis M, Charo IF. 2000. A mechanism for the impaired IFN-γ production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J. Immunol. 165:7072-77
109. Scott HM, Flynn JL. 2002. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70:5946-54
110. Kirkaldy AA, Musonda AC, Khanolkhar-Young S, Suneetha S, Lockwood DN. 2003. Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions. Clin. Exp. Immunol. 134:447-53
111. Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11:653-60
112. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, et al. 2005. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 202:1649-58
113. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, et al. 1995. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155:4838-43
114. Brightbill HD, Library DH, Krutzik SR, Yang RB, Belisle JT, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-36
115. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, Nathan C, Xie QW, et al. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-302
116. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, et al. 2001. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 291:1544-47
117. +-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74:1015-25
118. + monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201:1761-69
119. Yap GS, Sher A. 1999. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201:240-47
120. Yap GS, Sher A. 2002. The use of germ line-mutated mice in understanding host-pathogen interactions. Cell. Microbiol. 4:627-34
121. Ling YM, Shaw MH, Ayala C, Coppens I, Taylor GA, et al. 2006. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203:2063-71
122. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. 2006. CD11c-and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107:309-16
123. Romani L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23
124. Hohl TM, Rivera A, Pamer EG. 2 006. Immunity to fungi. Curr. Opin. Immunol. 18:465-72
125. Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG. 1998. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J. Infect. Dis. 178:1472-82
126. Schaffner A, Douglas H, Braude M, Davis CE. 1983. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109-15
127. Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, et al. 2003. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect. Immun. 71:891-903
128. Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, et al. 2005. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect. Immun. 73:3714-24
129. Fan W, Kraus PR, Boily MJ, Heitman J. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 4:1420-33
130. Cortez KJ, Lyman CA, Kottilil S, Kim HS, Roilides E, et al. 2006. Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect. Immun. 74:2353-65
131. Traynor TR, Kuziel WA, Toews GB, Huffnagle GB. 2000. CCR2 expression determines T1 vs T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2021-27
132. Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. 2002. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168:4659-66
133. MackM, Cihak J, Simonis C, Luckow B, Proudfoot AE, et al. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166:4697-704
134. Blease K, Mehrad B, Lukacs NW, Kunkel SL, Standiford TJ, Hogaboam CM. 2001. Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J. Immunol. 166:1832-42
135. -/- mice. J. Immunol. 165:2603-11
136. Morrison BE, Park SJ, Mooney JM, Mehrad B. 2003. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112:1862-70
137. Leon B, Lopez-Bravo M, Ardavin C. 2005. Monocyte-derived dendritic cells. Semin. Immunol. 17:313-18
138. Bechetoille N, Andre V, Valladeau J, Perrier E, Dezutter-Dambuyant C. 2006. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. J. Leukoc. Biol. 80:45-58
139. Rotta G, Edwards EW, Sangaletti S, Bennett C, Ronzoni S, et al. 2003. Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J. Exp. Med. 198:1253-63
140. Mbina JE, Henry WL Jr. 1991. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50:403-9
141. Lu L, Bonham CA, Chambers FG, Watkins SC, Hoffman RA, et al. 1996. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J. Immunol. 157:3577-86
142. Caspar-Bauguil S, Puissant B, Nazzal D, Lefevre JC, Thomsen M, et al. 2000. Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression. J. Infect. Dis. 182:1394-401
143. Hessle C, Andersson B, Wold AE. 2000. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68:3581-86
144. Park DR, Skerrett SJ. 1996. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-γ: differential responses of blood monocytes and alveolar macrophages. J. Immunol. 157:2528-38
145. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M. 2005. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106:2818-26
146. Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR. 1996. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:2846-49
147. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101:4560-65
148. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. 2006. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J. Leukoc. Biol. 79:285-93
149. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463-74
150. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652-56
151. Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM. 2007. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect. Immun. 75:653-65
152. Tacke F, Ginhoux F, Jakubzick C, van Rooijen N, Merad M, Randolph GJ. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203:583-97
153. Balazs M, Martin F, Zhou T, Kearney J. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341-52
154. Rot A, von Andrian UH. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928
155. Tsou CL, Haskell CA, Charo IF. 2001. Tumor necrosis factor-α- converting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 276:44622-26
156. DiTirro J, Rhoades ER, Roberts AD, Burke JM, Mukasa A, et al. 1998. Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect. Immun. 66:2284-89
157. Barsig J, Flesch IE, Kaufmann SH. 1998. Macrophages and hepatocyticcells as chemokine producers in murine listeriosis. Immunobiology 199:87-104
158. Denney CF, Eckmann L, Reed SL. 1999. Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect. Immun. 67:1547-52
159. Brenier-Pinchart MP, Pelloux H, Simon J, Ricard J, Bosson JL, Ambroise-Thomas P. 2000. Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro. Mol. Cell. Biochem. 209:79-87
160. Brenier-Pinchart MP, Vigan I, Jouvin-Marche E, Marche PN, Pelet E, et al. 2002. Monocyte chemotactic protein-1 secretion and expression after Toxoplasma gondii infection in vitro depend on the stage of the parasite. FEMS Microbiol. Lett. 214:45-49
161. Brenier-Pinchart MP, Blanc-Gonnet E, Marche PN, Berger F, Durand F, et al. 2004. Infection of human astrocytes and glioblastoma cells with Toxoplasma gondii: monocyte chemotactic protein-1 secretion and chemokine expression in vitro. Acta Neuropathol. 107:245-49
162. Lin Y, Gong J, Zhang M, Xue W, Barnes PF. 1998. Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect. Immun. 66:2319-22
163. Fujita M, Furukawa Y, Nagasawa Y, Ogawa M, Nakamura Y. 2000. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Cancer Res. 60:6683-87
164. Toney LM, Cattoretti G, Graf JA, Merghoub T, Pandolfi PP, et al. 2000. BCL-6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1:214-20
165. Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF, Luster AD. 1997. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J. Exp. Med. 185:99-109
166. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, et al. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:157-67
167. Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. 2006. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35:175-81
168. Colotta F, Borre A, Wang JM, Tattanelli M, Maddalena F, et al. 1992. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J. Immunol. 148:760-65
169. Struyf S, Van Collie E, Paemen L, Put W, Lenaerts JP, et al. 1998. Synergistic induction of MCP-1 and -2 by IL-1β and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63:364-72
170. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, et al. 2002. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169:2026-33
171. Rollins BJ, Pober JS. 1991. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am. J. Pathol. 138:1315-19
172. Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, Westwick J. 1994. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-γ. Am. J. Pathol. 145:913-21
173. Poon M, Liu B, Taubman MB. 1999. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol. Cell. Biol. 19:6471-78
174. Masumoto J, Yang K, Varambally S, Hasegawa M, Tomlins SA, et al. 2006. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J. Exp. Med. 203:203-13
175. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, et al. 2007. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J. Immunol. 179:514-21
176. Kim JY, Ahn MH, Song HO, Choi JH, Ryu JS, et al. 2006. Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii. Korean J. Parasitol. 44:197-207
177. Fietta AM, Morosini M, Meloni F, Bianco AM, Pozzi E. 2002. Pharmacological analysis of signal transduction pathways required for Mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes. Cytokine 19:242-49
178. Ping D, Jones PL, Boss JM. 1996. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. Immunity 4:455-69
179. Boekhoudt GH, Guo Z, Beresford GW, Boss JM. 2003. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 170:4139-47
180. Kumar SN, Boss JM. 2000. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1. Mol. Immunol. 37:623-32
181. Ping D, Boekhoudt G, Boss JM. 1999. trans-retinoic acid blocks platelet-derived growth factor-BB-induced expression of the murine monocyte chemoattractant-1 gene by blocking the assembly of a promoter proximal Sp1 binding site. J. Biol. Chem. 274:31909-16
182. Ping D, Boekhoudt G, Zhang F, Morris A, Philipsen S, et al. 2000. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J. Biol. Chem. 275:1708-14
183. Ping D, Boekhoudt GH, Rogers EM, Boss JM. 1999. Nuclear factor-κB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J. Immunol. 162:727-34
184. Teferedegne B, Green MR, Guo Z, Boss JM. 2006. Mechanism of action of a distal NF-κB-dependent enhancer. Mol. Cell. Biol. 26:5759-70
185. Kawahara RS, Deng ZW, Deuel TF. 1991. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J. Biol. Chem. 266:13261-66
186. Mukaida N, Zachariae CC, Gusella GL, Matsushima K. 1991. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J. Immunol. 146:1212-15
187. Paine R 3rd, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, Strieter RM. 1993. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 150:4561-70
188. Dhawan L, Liu B, Blaxall BC, Taubman MB. 2007. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability. J. Biol. Chem. 282:10146-52
189. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, et al. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100:1885-90
190. Johnson Z, Proudfoot AE, Handel TM. 2005. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 16:625-36
191. Lau EK, Paavola CD, Johnson Z, Gaudry JP, Geretti E, et al. 2004. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279:22294-305
192. Chakravarty L, Rogers L, Quach T, Breckenridge S, Kolattukudy PE. 1998. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273:29641-47
193. Yu Y, Sweeney MD, Saad OM, Crown SE, Hsu AR, et al. 2005. Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280:32200-8
194. Allen SJ, Crown SE, Handel TM. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25:787-820
195. Mora JR, Iwata M, Eksteen B, Song S-Y, Junt T, et al. 2006. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314:1157-60
196. Tezuka H, Abe Y, Iwata M, Takeuchi H, Ishikawa H, et al. 2007. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448:929-33
197. Taylor PR, Brown GD, Geldhof AB, Martinez-Romares LM, Gordon S. 2003. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 33:2090-97
198. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek S, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117:185-94
199. Grage-Griebenow E, Flad H, Ernst M. 2001. Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69:11-20
200. + monocyte subset. Am. J. Physiol. 276:H1144-49